{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T19:07:09Z","timestamp":1787598429682,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011390","name":"Key Laboratory of Industrial Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011390","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.xphs.2019.02.004","type":"journal-article","created":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T11:11:14Z","timestamp":1550574674000},"page":"2288-2295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Quality by Design-Driven Process Development of Cell Culture in Bioreactor for the Production of Foot-And-Mouth Veterinary Vaccine"],"prefix":"10.1016","volume":"108","author":[{"given":"Xinran","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuerong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongbin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanglan","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqi","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunde","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadji","family":"Ahamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuxia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yankun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghu","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"109","key":"10.1016\/j.xphs.2019.02.004_bib1","first-page":"27325","article-title":"International conference on harmonisation; guidance on Q8(R1) pharmaceutical development; addition of annex; availability","volume":"74","year":"2009","journal-title":"Notice Fed Regist"},{"issue":"106","key":"10.1016\/j.xphs.2019.02.004_bib2","first-page":"32105","article-title":"International conference on harmonisation; guidance on Q9 quality risk management; availability","volume":"71","year":"2006","journal-title":"Notice Fed Regist"},{"issue":"66","key":"10.1016\/j.xphs.2019.02.004_bib3","first-page":"15990","article-title":"International conference on harmonisation; guidance on Q10 pharmaceutical quality system; availability","volume":"74","year":"2009","journal-title":"Notice Fed Regist"},{"issue":"224","key":"10.1016\/j.xphs.2019.02.004_bib4","first-page":"69634","article-title":"International conference on harmonisation; guidance on Q11 development and manufacture of drug substances; availability","volume":"77","year":"2012","journal-title":"Notice Fed Regist"},{"issue":"7","key":"10.1016\/j.xphs.2019.02.004_bib5","doi-asserted-by":"crossref","first-page":"947","DOI":"10.3109\/03639045.2012.699065","article-title":"Quality risk management in pharmaceutical development","volume":"39","author":"Charoo","year":"2013","journal-title":"Drug Dev Ind Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2019.02.004_bib6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/nbt0109-26","article-title":"Quality by design for biopharmaceuticals","volume":"27","author":"Rathore","year":"2009","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.xphs.2019.02.004_bib7","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jbiotec.2014.08.026","article-title":"Evaluating the impact of cell culture process parameters on monoclonal antibody N-glycosylation","volume":"188","author":"Ivarsson","year":"2014","journal-title":"J\u00a0Biotechnol"},{"issue":"7","key":"10.1016\/j.xphs.2019.02.004_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/biot.201600546","article-title":"Quality by control: towards model predictive control of mammalian cell culture bioprocesses","volume":"12","author":"Sommeregger","year":"2017","journal-title":"Biotechnol J"},{"key":"10.1016\/j.xphs.2019.02.004_bib9","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jbiotec.2014.12.003","article-title":"Determination of the maximum operating range of hydrodynamic stress in mammalian cell culture","volume":"194","author":"Neunstoecklin","year":"2015","journal-title":"J\u00a0Biotechnol"},{"issue":"4","key":"10.1016\/j.xphs.2019.02.004_bib10","first-page":"34","article-title":"An introduction to mammalian cell culture","volume":"112","author":"Le","year":"2016","journal-title":"Chem Eng Prog"},{"issue":"1","key":"10.1016\/j.xphs.2019.02.004_bib11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/btpr.2402","article-title":"Exploring the linkage between cell culture process parameters and downstream processing utilizing a plackett-burman design for a model monoclonal antibody","volume":"33","author":"Agarabi","year":"2017","journal-title":"Biotechnol Prog"},{"issue":"3","key":"10.1016\/j.xphs.2019.02.004_bib12","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/btpr.2264","article-title":"Characterization of a Saccharomyces cerevisiae fermentation process for production of a therapeutic recombinant protein using a multivariate Bayesian approach","volume":"32","author":"Fu","year":"2016","journal-title":"Biotechnol Prog"},{"issue":"5","key":"10.1016\/j.xphs.2019.02.004_bib13","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/btpr.2295","article-title":"Toward intensifying design of experiments in upstream bioprocess development: an industrial Escherichia coli feasibility study","volume":"32","author":"Von Stosch","year":"2016","journal-title":"Biotechnol Prog"},{"issue":"24","key":"10.1016\/j.xphs.2019.02.004_bib14","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1016\/j.vaccine.2014.02.034","article-title":"Quantitative high throughput analytics to support polysaccharide production process development","volume":"32","author":"Noyes","year":"2014","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.xphs.2019.02.004_bib15","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1002\/bit.25580","article-title":"High throughput screening of particle conditioning operations: II. Evaluation of scale-up heuristics with prokaryotically expressed polysaccharide vaccines","volume":"112","author":"Noyes","year":"2015","journal-title":"Biotechnol Bioeng"},{"issue":"20","key":"10.1016\/j.xphs.2019.02.004_bib16","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.4155\/bio.13.198","article-title":"Quality by design for a vaccine release immunoassay: a case study","volume":"5","author":"Yarovoi","year":"2013","journal-title":"Bioanalysis"},{"issue":"5","key":"10.1016\/j.xphs.2019.02.004_bib17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.biologicals.2016.06.005","article-title":"Determination of critical quality attributes for monoclonal antibodies using quality by design principles","volume":"44","author":"Alt","year":"2016","journal-title":"Biologicals"},{"issue":"5","key":"10.1016\/j.xphs.2019.02.004_bib18","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.biologicals.2016.07.004","article-title":"Introduction to the application of QbD principles for the development of monoclonal antibodies","volume":"44","author":"Finkler","year":"2016","journal-title":"Biologicals"},{"issue":"3","key":"10.1016\/j.xphs.2019.02.004_bib19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4103\/2230-973X.187350","article-title":"Pharmaceutical product development: a quality by design approach","volume":"6","author":"Pramod","year":"2016","journal-title":"Int J Pharm Investig"},{"issue":"5","key":"10.1016\/j.xphs.2019.02.004_bib20","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.biologicals.2016.06.004","article-title":"Process characterization and design space definition","volume":"44","author":"Hakemeyer","year":"2016","journal-title":"Biologicals"},{"key":"10.1016\/j.xphs.2019.02.004_bib21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jconrel.2016.11.018","article-title":"Quality by design (QbD) approach of pharmacogenomics in drug designing and formulation development for optimization of drug delivery systems","volume":"245","author":"Gupta","year":"2017","journal-title":"J\u00a0Control Release"},{"issue":"5","key":"10.1016\/j.xphs.2019.02.004_bib22","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1586\/erv.09.19","article-title":"Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines","volume":"8","author":"Barrett","year":"2009","journal-title":"Expert Rev Vaccin"},{"issue":"5","key":"10.1016\/j.xphs.2019.02.004_bib23","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1007\/s00253-015-7267-9","article-title":"Bioreactors for high cell density and continuous multi-stage cultivations: options for process intensification in cell culture-based viral vaccine production","volume":"100","author":"Tapia","year":"2016","journal-title":"Appl Microbiol Biotechnol"},{"issue":"5","key":"10.1016\/j.xphs.2019.02.004_bib24","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/biot.201400388","article-title":"Designing cell lines for viral vaccine production: where do we stand?","volume":"10","author":"Genzel","year":"2015","journal-title":"Biotechnol J"},{"issue":"1","key":"10.1016\/j.xphs.2019.02.004_bib25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0166-0934(98)00071-8","article-title":"Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in\u00a0vitro","volume":"74","author":"Rimmelzwaan","year":"1998","journal-title":"J\u00a0Virol Methods"},{"key":"10.1016\/j.xphs.2019.02.004_bib26","first-page":"209","article-title":"Further developments in the quantification of small RNA viruses by U.V. photometry of sucrose density gradients","volume":"50","author":"Doel","year":"1981","journal-title":"Dev Biol Stand"},{"issue":"1","key":"10.1016\/j.xphs.2019.02.004_bib27","first-page":"107","article-title":"[Physical chemical measurement of 140S particles of the foot-and-mouth disease virus]","volume":"121","author":"Fayet","year":"1971","journal-title":"Ann Inst Pasteur (Paris)"},{"issue":"1","key":"10.1016\/j.xphs.2019.02.004_bib29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1021\/bp060359c","article-title":"Using statistical analysis for setting process validation acceptance criteria for biotech products","volume":"23","author":"Wang","year":"2007","journal-title":"Biotechnol Prog"},{"key":"10.1016\/j.xphs.2019.02.004_bib30","series-title":"Comprehensive Chemometrics","article-title":"Batch processes: modelling, analysis and control","author":"Wold","year":"2008"},{"issue":"6","key":"10.1016\/j.xphs.2019.02.004_bib31","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1002\/btpr.672","article-title":"Application of quality by design principles to the development and technology transfer of a major process improvement for the manufacture of a recombinant protein","volume":"27","author":"Looby","year":"2011","journal-title":"Biotechnol Prog"},{"issue":"24","key":"10.1016\/j.xphs.2019.02.004_bib32","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1016\/j.vaccine.2014.02.028","article-title":"Implementation of QbD for the development of a vaccine candidate","volume":"32","author":"Haas","year":"2014","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.xphs.2019.02.004_bib33","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1021\/bp070338y","article-title":"Defining process design space for biotech products: case study of Pichia pastoris fermentation","volume":"24","author":"Harms","year":"2008","journal-title":"Biotechnol Prog"},{"issue":"Suppl 8","key":"10.1016\/j.xphs.2019.02.004_bib34","doi-asserted-by":"crossref","first-page":"P12","DOI":"10.1186\/1753-6561-5-S8-P12","article-title":"The way to a design space for an animal cell culture process according to Quality by Design (QbD)","volume":"5","author":"Puskeiler","year":"2011","journal-title":"BMC Proc"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354919300899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354919300899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:25:56Z","timestamp":1758360356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354919300899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0022354919300899"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2019.02.004","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality by Design-Driven Process Development of Cell Culture in Bioreactor for the Production of Foot-And-Mouth Veterinary Vaccine","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2019.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}